REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Novo Nordisk Colombia Sas (Colombia)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Novo Nordisk Colombia Sas Profile Updated: March 15, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Spanish Download a sample report

The company Novo Nordisk Colombia Sas is primarily engaged in drugs and druggists' sundries merchant wholesalers and related activities. It's been operating in the Colombian market since 2012.

Headquarters
Cl 125 19 24 P 6
Bogota D.C.; Bogota D.C; Postal Code: 1012

Contact Details: Purchase the Novo Nordisk Colombia Sas report to view the information.

Basic Information
Total Employees:
Purchase the Novo Nordisk Colombia Sas report to view the information.
Outstanding Shares:
Purchase the Novo Nordisk Colombia Sas report to view the information.
Incorporation Date:
September 27, 2012
Key Executives
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Alternate Legal Representative
Purchase this report to view the information.
Alternate Legal Representative
Purchase this report to view the information.
Alternate Legal Representative
Ownership Details
Purchase this report to view the information.
Company Performance
Financial values in the chart are available after Novo Nordisk Colombia Sas report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Net sales revenue
22.27%▲
Total operating revenue
21.37%▲
Operating profit (EBIT)
-2.02%▼
EBITDA
-0.16%▼
Net Profit (Loss) for the Period
-55.56%▼
Total assets
19.72%▲
Total equity
6.93%▲
Operating Profit Margin (ROS)
-0.87%▼
Net Profit Margin
-1.22%▼
Return on Equity (ROE)
-9.12%▼
Debt to Equity Ratio
-7.48%▼
Quick Ratio
-0.11%▼
Cash Ratio
-0.03%▼

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo